Dean R Kahn (Dean Kahn)

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, James T Brewster Ii, Adam Cook, Amy L Crooks, Cole Cruz, Natalie C Dwulet, John J Gaudino, Daniel Golec, Jacqueline A Harrison, Dylan P Hartley, Sherif H Hassanien, Erik J Hicken, Dean R Kahn, Ellen R Laird, Christine Lemieux, Nicholas Lewandowski, Joseph McCown, Matthew G McDonald, Oren McNulty, Tung-Chung Mou, Phong Nguyen, Lauren Oko, Lisa Pieti Opie, Jennifer Otten, Spencer C Peck, Viktor C Polites, Samuel D Randall, Rachel Z Rosen, Pavel Savechenkov, Helen Simpson, Anurag Singh, Drew Sparks, Kyle Wickersham, Lance Wollenberg, Christina E Wong, Jim Wong, Wen-I Wu, Mohamed S A Elsayed, Ronald J Hinklin, Tony P Tang
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry (2024)
Li Ren, David Moreno, Brian R Baer, Patrick Barbour, Tanna Bettendorf, Karyn Bouhana, Karin Brown, Suzy A Brown, Jay B Fell, Dylan P Hartley, Erik J Hicken, Ellen R Laird, Patrice Lee, Joseph McCown, Jennifer N Otten, Brett Prigaro, Ross Wallace, Dean R Kahn
Identification of the Clinical Candidate PF-07284890 ( ARRY-461 ), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 67 (15) (2024)
Li Ren, David Moreno, Brian R Baer, Patrick Barbour, Tanna Bettendorf, Karyn Bouhana, Karin Brown, Suzy A Brown, Jay B Fell, Dylan P Hartley, Erik J Hicken, Ellen R Laird, Patrice Lee, Joseph McCown, Jennifer N Otten, Brett Prigaro, Ross Wallace, Dean R Kahn
Identification of the Clinical Candidate PF-07284890 ( ARRY-461 ), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 67 (15) (2024)
Rona Yaeger, Meredith A McKean, Rizwan Haq, J Thaddeus Beck, Matthew H Taylor, Jonathan Eliezer Cohen, Daniel W Bowles, Shirish M Gadgeel, Catalin Mihalcioiu, Kyriakos P Papadopoulos, Eli L Diamond, Keren B Sturtz, Gang Feng, Stefanie K Drescher, Micaela B Reddy, Bhaswati Sengupta, Arnab Kumar Maity, Suzy A Brown, Anurag Singh, Eric N Brown, Brian R Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R Kahn, Sunyana Gadal, Neal X Rosen, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation. Cancer discovery (2024)
Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, James T Brewster Ii, Adam Cook, Amy L Crooks, Cole Cruz, Natalie C Dwulet, John J Gaudino, Daniel Golec, Jacqueline A Harrison, Dylan P Hartley, Sherif H Hassanien, Erik J Hicken, Dean R Kahn, Ellen R Laird, Christine Lemieux, Nicholas Lewandowski, Joseph McCown, Matthew G McDonald, Oren McNulty, Tung-Chung Mou, Phong Nguyen, Lauren Oko, Lisa Pieti Opie, Jennifer Otten, Spencer C Peck, Viktor C Polites, Samuel D Randall, Rachel Z Rosen, Pavel Savechenkov, Helen Simpson, Anurag Singh, Drew Sparks, Kyle Wickersham, Lance Wollenberg, Christina E Wong, Jim Wong, Wen-I Wu, Mohamed S A Elsayed, Ronald J Hinklin, Tony P Tang
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry 67 (16) (2024)
Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, James T Brewster Ii, Adam Cook, Amy L Crooks, Cole Cruz, Natalie C Dwulet, John J Gaudino, Daniel Golec, Jacqueline A Harrison, Dylan P Hartley, Sherif H Hassanien, Erik J Hicken, Dean R Kahn, Ellen R Laird, Christine Lemieux, Nicholas Lewandowski, Joseph McCown, Matthew G McDonald, Oren McNulty, Tung-Chung Mou, Phong Nguyen, Lauren Oko, Lisa Pieti Opie, Jennifer Otten, Spencer C Peck, Viktor C Polites, Samuel D Randall, Rachel Z Rosen, Pavel Savechenkov, Helen Simpson, Anurag Singh, Drew Sparks, Kyle Wickersham, Lance Wollenberg, Christina E Wong, Jim Wong, Wen-I Wu, Mohamed S A Elsayed, Ronald J Hinklin, Tony P Tang
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry 67 (16) (2024)
Li Ren, David Moreno, Brian R Baer, Patrick Barbour, Tanna Bettendorf, Karyn Bouhana, Karin Brown, Suzy A Brown, Jay B Fell, Dylan P Hartley, Erik J Hicken, Ellen R Laird, Patrice Lee, Joseph McCown, Jennifer N Otten, Brett Prigaro, Ross Wallace, Dean R Kahn
Identification of the Clinical Candidate PF-07284890 ( ARRY-461 ), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry (2024)

Dean R Kahn.css-eqlu8i{font-size:small;padding-left:4px;} (Dean Kahn)

Publication Activity (10 Years)

Top Topics

Top Venues

Dean R Kahn (Dean Kahn)